TherVacB - A Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate

Clinical trial NCT06513286 · RECRUITING

Trial details

NCT number: NCT06513286
Sponsor: Michael Hoelscher
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis B

Start date: 2025-06-12
Primary completion: 2026-12-01
Enrollment: 81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.